Literature DB >> 11726638

The fate of heterotopically grafted neural precursor cells in the normal and dystrophic adult mouse retina.

S Pressmar1, M Ader, G Richard, M Schachner, U Bartsch.   

Abstract

PURPOSE: To study the integration and differentiation of heterotopically transplanted neural precursor cells in the retina of adult mouse mutants displaying apoptotic degeneration of photoreceptor cells.
METHODS: Neural precursor cells were isolated from the spinal cord of transgenic mouse embryos ubiquitously expressing enhanced green fluorescent protein. Cells were expanded in vitro and transplanted into the retina of adult wild-type and age-matched beta2/beta1 knock-in mice. Beta2/beta1 knock-in mutants display apoptotic death of photoreceptor cells and were generated by placing the cDNA of the beta1 subunit into the gene of the beta2 subunit of Na,K-ATPase. The integration and differentiation of grafted cells in recipient retinas was studied 1 or 6 months after transplantation.
RESULTS: Mutant retinas contained more donor-derived cells than wild-type hosts. Moreover, in mutants, donor cells integrated into deeper retinal layers. In both genotypes, grafted cells differentiated into astrocytes and oligodendrocytes. Only a few ganglion cell axons were myelinated by donor-derived oligodendrocytes 1 month after transplantation, whereas extensive myelination of the nerve fiber layer was observed 6 months after transplantation. Unequivocal evidence for differentiation of grafted cells into neurons was not obtained.
CONCLUSIONS: Heterotopically transplanted neural precursor cells are capable of integrating, surviving, and differentiating into neural cell types in normal and dystrophic retinas of adult mice. The particular environment of a pathologically altered retina facilitates integration of transplanted precursor cells. In principle, neural precursors may thus be useful to substitute for or replace dysfunctional or degenerated cell types. Results of the present study also indicate that replacement of retinal cell types is likely to require more appropriate donor cells, such as retinal precursor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726638

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate.

Authors:  Kriss Canola; Brigitte Angénieux; Meriem Tekaya; Alexander Quiambao; Muna I Naash; Francis L Munier; Daniel F Schorderet; Yvan Arsenijevic
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-01       Impact factor: 4.799

2.  Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors.

Authors:  Jason S Meyer; Martin L Katz; Joel A Maruniak; Mark D Kirk
Journal:  Stem Cells       Date:  2005-08-25       Impact factor: 6.277

Review 3.  [Stem cell-based therapies for retinal disorders].

Authors:  U Bartsch; S J Linke; B Petrowitz
Journal:  Ophthalmologe       Date:  2005-07       Impact factor: 1.059

4.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

5.  Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion.

Authors:  Na Li; Xiao-rong Li; Jia-qin Yuan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-16       Impact factor: 3.117

6.  Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina.

Authors:  Gila Jung; Jing Sun; Bettina Petrowitz; Kristoffer Riecken; Katharina Kruszewski; Wanda Jankowiak; Frank Kunst; Christos Skevas; Gisbert Richard; Boris Fehse; Udo Bartsch
Journal:  Stem Cells Transl Med       Date:  2013-10-28       Impact factor: 6.940

7.  An Endostatin-lentivirus (ES-LV)-EPC gene therapy agent for suppression of neovascularization in oxygen-induced retinopathy rat model.

Authors:  Jing Ai; Jian Ma; Zhi-Qing Chen; Jun-Hui Sun; Ke Yao
Journal:  BMC Mol Cell Biol       Date:  2020-07-29

8.  In vitro expanded stem cells from the developing retina fail to generate photoreceptors but differentiate into myelinating oligodendrocytes.

Authors:  Magdalena Czekaj; Jochen Haas; Marlen Gebhardt; Thomas Müller-Reichert; Peter Humphries; Jane Farrar; Udo Bartsch; Marius Ader
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.